Piramal Pharma Statistics
Total Valuation
Piramal Pharma has a market cap or net worth of INR 274.26 billion. The enterprise value is 317.62 billion.
Market Cap | 274.26B |
Enterprise Value | 317.62B |
Important Dates
The last earnings date was Friday, May 9, 2025.
Earnings Date | May 9, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Piramal Pharma has 1.33 billion shares outstanding. The number of shares has increased by 4.41% in one year.
Current Share Class | 1.33B |
Shares Outstanding | 1.33B |
Shares Change (YoY) | +4.41% |
Shares Change (QoQ) | +7.88% |
Owned by Insiders (%) | 0.20% |
Owned by Institutions (%) | 23.40% |
Float | 611.07M |
Valuation Ratios
The trailing PE ratio is 300.96 and the forward PE ratio is 144.17. Piramal Pharma's PEG ratio is 1.58.
PE Ratio | 300.96 |
Forward PE | 144.17 |
PS Ratio | 3.00 |
PB Ratio | 3.38 |
P/TBV Ratio | 6.79 |
P/FCF Ratio | 120.33 |
P/OCF Ratio | 30.74 |
PEG Ratio | 1.58 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.93, with an EV/FCF ratio of 139.36.
EV / Earnings | 348.53 |
EV / Sales | 3.47 |
EV / EBITDA | 20.93 |
EV / EBIT | 45.28 |
EV / FCF | 139.36 |
Financial Position
The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.60.
Current Ratio | 1.54 |
Quick Ratio | 0.76 |
Debt / Equity | 0.60 |
Debt / EBITDA | 3.36 |
Debt / FCF | 21.31 |
Interest Coverage | 1.49 |
Financial Efficiency
Return on equity (ROE) is 1.14% and return on invested capital (ROIC) is 3.07%.
Return on Equity (ROE) | 1.14% |
Return on Assets (ROA) | 2.54% |
Return on Invested Capital (ROIC) | 3.07% |
Return on Capital Employed (ROCE) | 5.28% |
Revenue Per Employee | 13.62M |
Profits Per Employee | 135,630 |
Employee Count | 6,719 |
Asset Turnover | 0.59 |
Inventory Turnover | 1.44 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +41.42% in the last 52 weeks. The beta is 0.08, so Piramal Pharma's price volatility has been lower than the market average.
Beta (5Y) | 0.08 |
52-Week Price Change | +41.42% |
50-Day Moving Average | 213.74 |
200-Day Moving Average | 226.80 |
Relative Strength Index (RSI) | 46.78 |
Average Volume (20 Days) | 4,438,220 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Piramal Pharma had revenue of INR 91.51 billion and earned 911.30 million in profits. Earnings per share was 0.68.
Revenue | 91.51B |
Gross Profit | 59.20B |
Operating Income | 6.28B |
Pretax Income | 4.15B |
Net Income | 911.30M |
EBITDA | 14.04B |
EBIT | 6.28B |
Earnings Per Share (EPS) | 0.68 |
Balance Sheet
The company has 5.21 billion in cash and 48.56 billion in debt, giving a net cash position of -43.35 billion or -32.62 per share.
Cash & Cash Equivalents | 5.21B |
Total Debt | 48.56B |
Net Cash | -43.35B |
Net Cash Per Share | -32.62 |
Equity (Book Value) | 81.25B |
Book Value Per Share | 61.40 |
Working Capital | 20.31B |
Cash Flow
In the last 12 months, operating cash flow was 8.92 billion and capital expenditures -6.64 billion, giving a free cash flow of 2.28 billion.
Operating Cash Flow | 8.92B |
Capital Expenditures | -6.64B |
Free Cash Flow | 2.28B |
FCF Per Share | 1.71 |
Margins
Gross margin is 64.69%, with operating and profit margins of 6.87% and 1.00%.
Gross Margin | 64.69% |
Operating Margin | 6.87% |
Pretax Margin | 4.53% |
Profit Margin | 1.00% |
EBITDA Margin | 15.34% |
EBIT Margin | 6.87% |
FCF Margin | 2.49% |
Dividends & Yields
This stock pays an annual dividend of 0.14, which amounts to a dividend yield of 0.07%.
Dividend Per Share | 0.14 |
Dividend Yield | 0.07% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 1 |
Payout Ratio | 15.88% |
Buyback Yield | -4.41% |
Shareholder Yield | -4.35% |
Earnings Yield | 0.33% |
FCF Yield | 0.83% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |